“Global Cyclodextrin Market to reach a market value of USD 504.3 Million by 2031 growing at a CAGR of 5.6%”
The Global Cyclodextrin Market size is expected to reach $504.3 million by 2031, rising at a market growth of 5.6% CAGR during the forecast period. In the year 2023, the market attained a volume of 873.18 Tonnes, experiencing a growth of 17.7% (2020-2023).
Cyclodextrins are well-known for improving the solubility and bioavailability of poorly soluble drugs. Therefore, the pharmaceutical segment would acquire 34.8% revenue share by 2031. Moreover, the pharmaceutical segment utilized 289.62 Tonnes of Cyclodextrin in 2023. Many active pharmaceutical ingredients (APIs) have limited solubility in aqueous solutions, hindering their absorption and efficacy in pharmaceutical formulations.
Many drugs used to treat infectious diseases face challenges related to poor solubility, which can hinder their effectiveness. Cyclodextrins, with their ability to form inclusion complexes, can improve the solubility of these drugs. In addition, these increase their aqueous solubility by encapsulating poorly soluble drugs within their hydrophobic cavity, making them more bioavailable and efficacious. Thus, increasing drug formulation for infectious diseases drives the market’s growth.
Additionally, as urbanization progresses and incomes rise, there’s a notable shift in dietary preferences towards convenience and processed foods. These find extensive applications in the food and beverage industry as encapsulants for flavors, fragrances, and other functional ingredients. Therefore, the growing middle-class population and urbanization propel the market’s growth.
However, these can uniquely form inclusion complexes with poorly soluble drugs, improving their solubility and bioavailability. This property is particularly valuable in drug delivery systems were increasing the solubility and bioavailability of active pharmaceutical ingredients (APIs) can enhance drug efficacy and therapeutic outcomes. Thus, drug delivery system innovations are propelling the market’s growth.
On the basis of end-use, the market is segmented into food, pharmaceutical, cosmetics & personal care, chemical, textile, and others. The chemical segment held 15.4% growth rate in the market in 2023. These have a wide range of applications in the chemical industry. They are utilized as complex agents, solubilizers, stabilizers, and carriers for various chemical compounds. Moreover, in terms of volume, the chemical segment utilized 138.44 Tonnes of Cyclodextrin in 2023.
Based on type, the market is divided into alpha-cyclodextrin, beta-cyclodextrin, and gamma-cyclodextrin. The alpha-cyclodextrin segment attained 24.3% revenue share in the market in 2023. Alpha-cyclodextrin offers unique properties that make it particularly suitable for certain applications. Moreover, in terms of volume, the alpha-variant segment utilized 72.57 tonnes of Cyclodextrin in 2023.
Free Valuable Insights: Global Cyclodextrin Market size to reach USD 504.3 Million by 2031
Region-wise, the market is analyzed across North America, Europe, Asia Pacific, and LAMEA. In 2023, the Asia Pacific region generated 27.1% revenue share in the market. Consumers in the Asia Pacific region is becoming increasingly aware of health and wellness trends, leading to a surge in demand for functional foods, dietary supplements, and personal care products with added health benefits. In terms of volume, the Asia Pacific region would utilize 1,22,154.38 tonnes of Cyclodextrin by 2031.
| Report Attribute | Details |
|---|---|
| Market size value in 2023 | USD 329.3 Million |
| Market size forecast in 2031 | USD 504.3 Million |
| Base Year | 2023 |
| Historical Period | 2020 to 2022 |
| Forecast Period | 2024 to 2031 |
| Revenue Growth Rate | CAGR of 5.6% from 2024 to 2031 |
| Quantitative Data | Volume in Tonnes, Revenue in USD Million, and CAGR from 2020 to 2031 |
| Number of Pages | 275 |
| Number of Tables | 571 |
| Report coverage | Market Trends, Revenue Estimation and Forecast, Segmentation Analysis, Regional and Country Breakdown, Porter’s 5 Forces Analysis, Company Profiling, Companies Strategic Developments, SWOT Analysis, Winning Imperatives |
| Segments covered | Type, End-use, Region |
| Country scope |
|
| Companies Included | Midas Pharma Gmbh, Wacker Chemie AG, Roquette Freres SA, Cambrex Corporation, Wellona Pharma, Cayman Chemical Company, Inc., Cyclolab Kft., Ligand Pharmaceuticals Incorporated, Tocopharm Co. Limited, Merck KGaA |
By Type (Volume, Tonnes, USD Million, 2020-2031)
By End-use (Volume, Tonnes, USD Million, 2020-2031)
By Geography (Volume, Tonnes, USD Million, 2020-2031)
This Market size is expected to reach $504.3 million by 2031.
Increasing drug formulation for infectious diseases are driving the Market in coming years, however, High production costs of cyclodextrins restraints the growth of the Market.
Midas Pharma Gmbh, Wacker Chemie AG, Roquette Freres SA, Cambrex Corporation, Wellona Pharma, Cayman Chemical Company, Inc., Cyclolab Kft., Ligand Pharmaceuticals Incorporated, Tocopharm Co. Limited, Merck KGaA
In the year 2023, the market attained a volume of 873.18 Tonnes, experiencing a growth of 17.7% (2020-2023).
The Beta-Cyclodextrin segment is registering maximum revenue in the Market by Type in 2023; thereby, achieving a market value of $330.2 Million by 2031.
The North America region dominated the Market by Region in 2023, and would continue to be a dominant market till 2031; thereby, achieving a market value of $216.1 Million by 2031.
Our team of dedicated experts can provide you with attractive expansion opportunities for your business.
Unique Offerings 